Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MoreThe JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer
Read MorePublic health officials are urging eligible Americans to take all three shots so the nation can avoid another "tripledemic" of
Read MoreIt's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their
Read MoreBank of America's list of top European picks includes stocks ranging from Mercedes-Benz to GSK, and Shell to LVMH. Source
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MorePfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the
Read MoreThe approval of a vaccine by Pfizer targeting RSV comes just weeks after the Food and Drug Administration cleared a
Read MoreThe FDA is slated to make a decision on whether to approve Pfizer's shot in August before respiratory syncytial virus
Read MoreThe FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that
Read More